Back to Search
Start Over
Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D)
- Source :
- Diabetes Research and Clinical Practice. 140:9-17
- Publication Year :
- 2018
- Publisher :
- Elsevier BV, 2018.
-
Abstract
- In chronic kidney disease patients on dialysis (CKD-G5D) accurate assessment of glycemic control is vital to improve their outcome and survival. The best glycemic marker for glucose control in these patients is still debated because several clinical and pharmacological factors may affect the ability of the available biomarkers to reflect the patient's glycemic status properly. This review discusses the role of glycated albumin (GA) both as a biomarker for glucose control and as a prognostic factor in CKD-G5D; it also looks at the pros and cons of GA in comparison to the other markers and its usefulness in hemodialysis and peritoneal dialysis.
- Subjects :
- Blood Glucose
Glycation End Products, Advanced
Male
medicine.medical_specialty
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
030232 urology & nephrology
030209 endocrinology & metabolism
Gastroenterology
Peritoneal dialysis
03 medical and health sciences
0302 clinical medicine
Endocrinology
Renal Dialysis
Glycation
Internal medicine
Diabetes mellitus
Internal Medicine
medicine
Humans
Glycated Serum Albumin
Renal Insufficiency, Chronic
Serum Albumin
Dialysis
Aged
Glycemic
business.industry
General Medicine
Middle Aged
Prognosis
medicine.disease
Biomarker (medicine)
Female
Hemodialysis
business
Biomarkers
Kidney disease
Subjects
Details
- ISSN :
- 01688227
- Volume :
- 140
- Database :
- OpenAIRE
- Journal :
- Diabetes Research and Clinical Practice
- Accession number :
- edsair.doi.dedup.....6dcf9cae7692f271ac2a9e08dab7020c